New Scripps tech helps spot autoimmune disease biomarkers

Scripps Research Institute scientists came up with new technology that they say can successfully be used to screen human blood for biomarkers affecting various autoimmune diseases and other health conditions ranging from multiple sclerosis, lupus, Alzheimer's disease and narcolepsy. Their initial study involved spotting human blood biomarkers for neuromyelitis optica, an autoimmune disorder that is similar to multiple sclerosis and makes sufferers go blind and become paralyzed. And their technique has also worked in mouse studies for multiple sclerosis. One key: a search for peptoids that bind to antibodies found in patients that are known to have a specific disease. Details are published in the journal Chemistry & Biology. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.